GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

Dr. Steven Bialick discusses treatment options for pancreatic cancer.

Dr. Steven Bialick discusses the various symptoms that may be present with pancreatic cancer.

Dr. Steven Bialick discusses the types of lab tests done on patients with suspected pancreatic cancer, including CBC, CMP, CEA, and CA19-9.

Dr. Steven Bialick discusses genetic testing in pancreatic cancer, including the difference in germline and somatic testing, and which mutations may have known treatments.

Dr. Steven Bialick discusses the NCCN guidelines for diagnosing pancreatic cancer, as well as the various members of a patient's care team.

Dr. Steven Bialick discusses the main risk factors for pancreatic, including high BMI, smoking, and alcohol abuse.

Dr. Steven Bialick discusses how pancreatic cancer rates are increasing, and overall patterns of diagnosis.

Dr. Steven Bialick discusses the anatomy of pancreas cancer, including why a person may experience weight loss.

Dr. Steven Bialick discusses how location and stage affect prognosis in pancreatic cancer.

Dr. Steven Bialick discusses the types of imaging tests used in diagnosing pancreatic cancer, including CT and PET scans.

Dr. Fiorinda Muhaj discusses advanced BCC, and systemic therapy options for treatment.

Dr. Fiorinda Muhaj discusses the management of high-risk BCC.

Dr. Fiorinda Muhaj discusses the management of low-risk BCC.

Dr. Vernon Sondak discusses alternatives for non-surgical candidates with skin cancer, including systemic therapy.

Dr. Fiorinda Muhaj discusses the risk factors for developing BCC, and how it is diagnosed.

Dr. Vernon Sondak discusses the recent developments in systemic therapy to treat patients with skin cancer.

Dr. Vernon Sondak discusses potential downsides to Mohs surgery, and why not all patients will go that route. 

Dr. Vernon Sondak gives a brief overview of melanoma, and what warning signs to look for. He also gives important information regarding skin cancer prevention overall.

Dr. Fiorinda Muhaj discusses how patients with BCC can follow up after treatment, and how to help prevent future BCC occurrences.

Dr. Vernon Sondak explains what Mohs surgery is, and why it may be preferable in some cases.

Dr. Vernon Sondak discusses two common types of skin cancer: basal and squamous cell. He details their characteristics and statistics.

Dr. Vernon Sondak explains the basics of skin cancer facts: how prominent it is, who is at risk, and what it can look like.

Drs. Desai and Abu Rous discuss trial data from Flaura2 and Mariposa as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC.

Drs. Desai and Abu Rous discuss the Crown study data as presented at ASCO 2024, and its implications in treating ALK+ NSCLC.

Drs. Desai and Abu Rous discuss the  data, as presented at ASCO 2024, and how it may change the field of treatment for limited stage small Adriatic Studycell lung cancer.

Drs. Desai and Abu Rous discuss trial date from Mariposa2 and Laura as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC.

Drs. Desai and Abu Rous discuss using tarlatamab in treating extensive stage small cell lung cancer.

Dr. Vernon Sondak discusses what factors go into the decision on staging skin cancer, including the various guidelines that different doctors may use.

Drs. Patel, Sheth, and Weiss discuss emerging data and advances in thyroid cancer treatment.

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in incurable HPV negative head and neck cancer.

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in recurrent/metastatic HPV positive head and neck cancer.

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV negative head and neck cancer.

Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.

Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.

Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.

Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.

Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.

Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.

Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.

Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.

Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)

Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.

Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC

Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.

Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.

Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.

Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.

Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.